GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » OCI (XKRX:456040) » Definitions » Beginning Cash Position

OCI (XKRX:456040) Beginning Cash Position : ₩280,347 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is OCI Beginning Cash Position?

OCI's Beginning Cash Position for the quarter that ended in Mar. 2024 was ₩280,347 Mil.

OCI's quarterly Beginning Cash Position declined from Sep. 2023 (₩299,004 Mil) to Dec. 2023 (₩185,262 Mil) but then increased from Dec. 2023 (₩185,262 Mil) to Mar. 2024 (₩280,347 Mil).

OCI's annual Beginning Cash Position stayed the same from . 20 (₩0 Mil) to . 20 (₩0 Mil) but then increased from . 20 (₩0 Mil) to Dec. 2023 (₩300,921 Mil).


OCI Beginning Cash Position Historical Data

The historical data trend for OCI's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OCI Beginning Cash Position Chart

OCI Annual Data
Trend Dec23
Beginning Cash Position
300,920.60

OCI Quarterly Data
Jun23 Sep23 Dec23 Mar24
Beginning Cash Position - 299,003.65 185,262.17 280,346.80

OCI Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


OCI Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of OCI's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


OCI (XKRX:456040) Business Description

Industry
Traded in Other Exchanges
N/A
Address
94, Sogong-ro, Jung-gu, Seoul, KOR, 100-718
OCI is engaged in Solar PV Business, ESS (Energy Storage System), Cogeneration, Urban development projects, and Pharmaceutical-Bio business. The company will operate in Korea, China, and the United States.

OCI (XKRX:456040) Headlines

No Headlines